92596 ⎘
Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
IMPROVED PROCESSES FOR PREPARING DIMETHYL-2,3-DIHYDRO-1H-INDENE DERIVATIVES
#2AMINERGIC PHYTOCANNABINOIDS DERIVATIVES AS MULTI-TARGET AGENTS FOR NEUROLOGICAL DISORDERS
#3Compounds for the Treatment of Neurodegenerative Diseases
#4Selective Serotonin Receptor Modulators and Methods of Making and Using the Same
#5PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
#6PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
#7COMPOUND, CELLULAR VESICLE STAIN, AND METHOD FOR FLUORESCENT STAINING OF CELLULAR VESICLES
#8Phenethylamine compounds salts, polymorphic forms and methods of use thereof
#9PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
#10CO-CRYSTALS OF TRAMADOL AND COXIBS
#11MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA, AND PATHOGENIC YEAST
#12Substituted bicyclic compounds
#13Tramadol HBR-Celecoxib Co-Crystal
#14Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic yeast
#15Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
#16Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity
#17Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
#18Substituted bicyclic compounds
#19Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity
#20Co-crystals of tramadol and coxibs
#21MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA AND PATHOGENIC YEAST
#22Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria and pathogenic yeast
#23Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity
#24Difluorinated compounds as depigmenting or lightening agents
#25Co-crystals of tramadol and coxibs
#26Substituted bicyclic compounds
#27Dezocine analogue
#28Cyclopropylmethanamines as selective 5-HT(2C) receptor agonists
#29Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity
#30Cycloalkylamines as monoamine reuptake inhibitors
#31Method for the preparation of highly pure ivabradine base and salts thereof
#32Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#33Substituted Phenethylamines With Serotoninergic And/Or Norepinephrinergic Activity
#34(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#35Diphenethylamine derivatives which are inter alia useful as analgesics and method for their production
#36Therapeutic compounds and uses thereof
#37Processes for the Preparation of Rotigotine and Intermediates Thereof
#38Substituted bicyclic compounds
#39Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases
#40PHARMACEUTICAL SALTS
#41Serotonin receptor-targeting compounds and methods
#42Substituted bicyclic compounds
#43Co-crystals of tramadol and coxibs
#44Co-crystals of tramadol and coxibis
#45Buprenorphine dimer and its use in treatment of gastrointestinal disorders
#46PHARMACEUTICALLY ACTIVE DIMERS LINKED THROUGH PHENOLIC HYDROXYL GROUPS
#47(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
#48SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY
#49ENDODONTIC POST SYSTEM
#50PHENANTHRENE DERIVATIVES FOR USE AS MEDICAMENTS
#51Photolabile pro-fragrances
#52Suicidal LSD1 inhibitors targeting SOX2-expressing cancer cells
#53Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#54Substituted bicyclic compounds
#55Cyclopropylamine derivatives useful as LSD1 inhibitors
#56Lysine specific demethylase-1 inhibitors and their use
#57Hydroxy aliphatic substituted phenyl aminoalkyl ether derivatives
#58Therapeutic tetrahydronaphthalene compounds
#59Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A
#60DERIVATIVES OF (-)-VENLAFAXINE AND METHODS OF PREPARING AND USING THE SAME
#61Methods of treatment using arylcyclopropylamine compounds
#62Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#63Cycloalkylamines as monoamine reuptake inhibitors
#64Photolabile pro-fragrances
#65Substituted 4-aminocyclohexane derivatives
#66Co-crystals of tramadol and NSAIDs
#67METHODS OF TREATMENT USING ARYLCYCLOPROPYLAMINE COMPOUNDS
#68Amine derivative compounds for treating ophthalmic diseases and disorders
#69Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#70SUBSTITUTED BENZYLAMINE COMPOUNDS, THEIR USE IN MEDICINE, AND IN PARTICULAR THE TREATMENT OF HEPATITIS C VIRUS (HCV) INFECTION
#71Lysine specific demethylase-1 inhibitors and their use
#72Benzocycloheptane and benzoxepine derivatives
#73Process of preparing Grignard reagent
#74Methods of using derivatives of (−)-venlafaxine
#75Heterobicyclic sphingosine 1-phosphate analogs
#76Cycloalkylmethylamines
#77Co-crystals of tramadol and coxibs
#78Method of preparing (S)-2-amino-5-methoxytetralin hydrochloride
#79Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#80Methods of using cycloalkylmethylamine derivatives
#81Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
#82Aminotetraline derivatives
#83Analgesic compounds, methods, and formulations
#84Substituted 4-aminocyclohexane derivatives
#85Cyclopropylamine derivatives useful as LSD1 inhibitors
#86CALCIUM RECEPTOR-ACTIVE MOLECULES
#87Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#88METHODS OF TREATMENT USING ARYLCYCLOPROPYLAMINE COMPOUNDS
#89Polymorphic form of a calcimimetic compound
#90Polymorphic form of a calcimimetic compound
#91Lysine specific demethylase-1 inhibitors and their use
#92Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives
#93Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor
#94DICLOFENAC SALT OF TRAMADOL
#95CO-CRYSTALS OF VENLAFAXINE AND CELECOXIB
#96Benzocycloheptane and benzoxepine derivatives
#97Derivatives of venlafaxine and methods of preparing and using the same
#98CYCLOALKYLAMINE DERIVATIVES
#99Lysine Specific Demethylase-1 inhibitors and their use
#100Aminotetraline derivatives
#101Methods of using derivatives of (−)-venlafaxine
#102Substituted 4-aminocyclohexane derivatives
#103Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
#104Co-crystals of tramadol and coxibs
#105Therapeutic compounds
#106FTY720-derived anticancer agents
#107Cycloalkylamne derivatives
#108FLUORINE CONTAINING COMPOUNDS AND METHODS OF USE THEREOF
#109Pharmaceutical salts
#110Amine derivative compounds for treating ophthalmic diseases and disorders
#111Amine derivative compounds for treating ophthalmic diseases and disorders
#112Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome
#113Resolution of 4,5-dimethoxy-1-(methylaminomenthyl)-benzocyclobutane
#114Phenylcyclopropylamine derivatives and their medical use
#115Crystalline forms of (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)cyclohexane-1,3-diol hydrochloride
#1161-Phenyl-2-DimethylaminomethylCyclohexane Compounds and Therapies for Depressive Symptoms, Pain and Incontinence
#117CO-CRYSTALS OF TRAMADOL AND NSAIDs
#118Crystal forms of O-desmethylvenlafaxine fumarate
#119Processes for the preparation of arylamine compounds
#120SALTS OF TRAMADOL AND IBUPROFEN AND THEIR CRYSTAL FORM IN THE TREATMENT OF PAIN
#121Process for the preparation of optically active (S)-(−)-2-(N-propylamino)-5-methoxytetraline and (S)-(−)-2-(N-propylamino)-5-hydroxytetraline compounds
#122Crystalline Modifications of 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol
#123Benzocycloheptane and benzoxepine derivatives
#124Arylcyclopropylamines and methods of use
#125Cyclic hydrocarbon compounds for the treatment of diseases
#126Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
#127BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS
#128Salts of Tramadol and Naproxen and their crystal forms in the treatment of pain
#129METHOD FOR SALT PREPARATION
#130Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives
#131Cycloalkylamines as monoamine reuptake inhibitors
#132Heterobicyclic sphingosine 1-phosphate analogs
#133PROCESS FOR THE PREPARATION OF PHENETHYLAMINE DERIVATIVES
#134METHODS OF REDUCTION OF INTERPATIENT VARIABILITY
#135SALT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG AND ORGANIC AMINE COMPOUND AND USE THEREOF
#136Amine derivative compounds for treating ophthalmic diseases and disorders
#137PHARMACEUTICAL SALTS
#138Process for producing (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol
#139Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
#140Tetralin analogs having sphingosine 1-phosphate agonist activity
#141SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES
#142Processes for preparing venlafaxine and venlafaxine hydrochloride of form I
#143Process for producing 6-dimethylaminomethyl-phenyl-cyclohexane-1,3-diols
#144DEUTERIUM-ENRICHED AMIBEGRON
#145SUBSTITUTED CYCLOHEXANOLS
#146Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#147Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#148Derivatives of venlafaxine and methods of preparing and using the same
#149SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY
#150Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
#151Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
#152Dosage forms of O-desmethylvenlafaxine
#153In situ or one-pot hydrogenation and reductive amination process
#154Production method of phenylethanolamine compound, and its intermediate
#155Cycloalkylamines as monoamine reuptake inhibitors
#156Cyclic amine derivative or salt thereof
#157Tetralone-based monoamine reuptake inhibitors
#158Processes for preparing venlafaxine and venlafaxine hydrochloride of form I
#159Melanin concentrating hormone antagonist
#160Process for preparation of phenethylamine derivatives
#161Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
#162Process for chlorinating tertiary alcohols
#163Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
#164Process for the preparation of highly pure 1-[2- dimethylamino-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride
#165Tetrahydronaphthalene derivatives, processes for their preparation and their use as antiinflammatory agents
#166Enantiomers of N-Desmethyl venlafaxine
#167Tramadol recovery process
#168Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
#169Monoamine re-uptake inhibitors and methods relating thereto
#170Adduct of topiramate and tramadol hydrochloride and uses thereof
#171Calcium receptor-active molecules
#172Phosphate salts of 6-dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexane compounds
#173Enantiomers of N-desmethyl venlafaxine
#174Methods of using derivatives of (-)-venlafaxine
#175Salts of (-)-O-desmethylvenlafaxine
#176Venlafaxine hydrochloride monohydrate and methods for the preparation thereof
#177Enantiomers of N-desmethyl venlafaxine
#178Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
#179Crystalline forms of venlafaxine hydrochloride
#180N-bisaryl- and n-aryl-cycloakylidenyl-αhydroxy-and α-alkoxy acid amides
#181Manufacture of phenyl ethylamine compounds, in particular venlafaxine
#182Process for preparing 2-[(dimethylamino)-methyl]-1-(3-methoxyphenyl)cyclohexanol
#183O-desmethylvenlafaxine and methods of preparing and using the same
#1841-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
#185Pharmaceutical salts
#186Process for preparation of 2-aminotetralin derivatives and intermediates thereof
#187Process for chlorinating tertiary alcohols
#188Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
#189Process for the preparation of phenethylamine derivative, an intermediate of Venlafaxine hydrochloride